DLA
CVS icon

Douglas Lane & Associates’s CVS Health CVS Stock Holding History

Douglas Lane & Associates’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.4M Sell
284,112
-124,515
-30% -$11.1M 0.4% 86
2026
Q1 		$29.3M Sell
408,627
-27,502
-6% -$2.12M 0.42% 87
2025
Q4 		$34.6M Sell
436,129
-127,291
-23% -$10M 0.48% 84
2025
Q3 		$42.5M Sell
563,420
-28,965
-5% -$1.99M 0.59% 73
2025
Q2 		$40.9M Sell
592,385
-110,278
-16% -$7.23M 0.59% 66
2025
Q1 		$47.6M Buy
702,663
+12,567
+2% +$752K 0.7% 58
2024
Q4 		$31M Sell
690,096
-462,101
-40% -$25.9M 0.44% 90
2024
Q3 		$72.5M Sell
1,152,197
-9,520
-0.8% -$555K 1% 36
2024
Q2 		$68.6M Buy
1,161,717
+77,461
+7% +$4.85M 0.97% 39
2024
Q1 		$86.5M Buy
1,084,256
+16,840
+2% +$1.29M 1.22% 23
2023
Q4 		$84.3M Buy
1,067,416
+32,542
+3% +$2.32M 1.3% 24
2023
Q3 		$72.3M Buy
1,034,874
+119,111
+13% +$8.44M 1.21% 31
2023
Q2 		$63.3M Buy
915,763
+126,108
+16% +$8.97M 1.02% 40
2023
Q1 		$58.7M Buy
789,655
+16,800
+2% +$1.41M 0.98% 45
2022
Q4 		$72M Buy
772,855
+22,537
+3% +$2.17M 1.2% 36
2022
Q3 		$71.6M Buy
750,318
+15,170
+2% +$1.5M 1.32% 25
2022
Q2 		$68.1M Buy
735,148
+7,022
+1% +$685K 1.16% 33
2022
Q1 		$73.7M Buy
728,126
+26,113
+4% +$2.74M 1.04% 36
2021
Q4 		$72.4M Buy
702,013
+37,630
+6% +$3.48M 0.96% 37
2021
Q3 		$56.4M Buy
664,383
+58,957
+10% +$4.94M 0.81% 49
2021
Q2 		$50.5M Buy
605,426
+20,703
+4% +$1.7M 0.71% 57
2021
Q1 		$44M Buy
584,723
+39,899
+7% +$2.91M 0.68% 62
2020
Q4 		$37.2M Buy
544,824
+31,668
+6% +$2.06M 0.62% 64
2020
Q3 		$30M Buy
513,156
+68,277
+15% +$4.25M 0.59% 61
2020
Q2 		$28.9M Buy
444,879
+86,595
+24% +$5.45M 0.62% 56
2020
Q1 		$21.3M Buy
358,284
+267,770
+296% +$17.9M 0.56% 60
2019
Q4 		$6.72M Buy
90,514
+86,319
+2,058% +$6.06M 0.13% 103
2019
Q3 		$265K Buy
4,195
+257
+7% +$15.2K 0.01% 191
2019
Q2 		$215K Buy
3,938
+59
+2% +$3.18K ﹤0.01% 207
2019
Q1 		$209K Sell
3,879
-41
-1% -$2.53K ﹤0.01% 207
2018
Q4 		$257K Buy
3,920
+721
+23% +$53.8K 0.01% 189
2018
Q3 		$252K Buy
+3,199
New +$229K 0.01% 189
2017
Q4 		– Sell
-2,833
Closed -$230K – 203
2017
Q3 		$230K Sell
2,833
-311
-10% -$24.6K 0.01% 197
2017
Q2 		$253K Sell
3,144
-60
-2% -$4.74K 0.01% 188
2017
Q1 		$252K Sell
3,204
-940
-23% -$75K 0.01% 193
2016
Q4 		$327K Sell
4,144
-1,423
-26% -$115K 0.01% 186
2016
Q3 		$495K Sell
5,567
-3,898
-41% -$368K 0.01% 169
2016
Q2 		$906K Sell
9,465
-95
-1% -$9.47K 0.03% 157
2016
Q1 		$992K Buy
+9,560
New +$930K 0.03% 155

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Douglas Lane & Associates's CVS Position: Q2 2026 in Review

Douglas Lane & Associates reduced its CVS Health (CVS) stake by 30% in Q2 2026, selling an estimated $11.1M and leaving 284,112 shares worth $29.4M. The position accounts for 0.4% of the portfolio, ranked #86.

Douglas Lane & Associates first reported a position in CVS in Q1 2016 and has held it in 39 quarters since. The position peaked at $86.5M in Q1 2024. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Douglas Lane & Associates held 284,112 shares of CVS Health worth $29.4M as of Q2 2026.
  • Douglas Lane & Associates sold 124,515 CVS Health shares in Q2 2026, an estimated $11.1M.
  • CVS Health made up 0.4% of Douglas Lane & Associates's portfolio in Q2 2026, its #86 holding.
  • Douglas Lane & Associates first reported a position in CVS Health in Q1 2016 and has held it in 39 quarters since.
  • Douglas Lane & Associates's CVS Health position peaked at $86.5M in Q1 2024.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Douglas Lane & Associates's 13F filing for Q2 2026, filed 14 Jul 2026.